Joseph E. Payne

Insider Reports History

Location
San Diego, CA
Signature
/s/ Ilan Katz, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph E. Payne:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vallon Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 7,500 $11,400 $1.52 09 Jun 2022 Direct
Arcturus Therapeutics Holdings Inc. President and CEO, Director Employee Stock Option (right to buy) 175,000 17 Dec 2025 Direct

Insider Reports Filed by Joseph E. Payne

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARCT Arcturus Therapeutics Holdings Inc. 17 Dec 2025 1 $0 4 President and CEO, Director 19 Dec 2025, 17:21
ARCT Arcturus Therapeutics Holdings Inc. 16 Dec 2024 1 $0 4 President and CEO, Director 18 Dec 2024, 16:06
ARCT Arcturus Therapeutics Holdings Inc. 15 Dec 2023 1 $0 4 President and CEO, Director 19 Dec 2023, 20:00
ARCT Arcturus Therapeutics Holdings Inc. 09 Dec 2022 1 $0 4 President and CEO, Director 13 Dec 2022, 15:07
ARCT Arcturus Therapeutics Holdings Inc. 23 Nov 2022 1 +$82,550 4 President and CEO, Director 28 Nov 2022, 15:07
ARCT Arcturus Therapeutics Holdings Inc. 21 Jun 2022 1 $0 4 President and CEO, Director 23 Jun 2022, 16:16
GRI Vallon Pharmaceuticals, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 13:32
GRI Vallon Pharmaceuticals, Inc. 25 May 2021 2 +$71,795 4 Director 27 May 2021, 20:37
GRI Vallon Pharmaceuticals, Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 16:09